COMPREHENSIVE LIPID PROFILE AMONG TYPE 2 DIABETES MELLITUS (T2DM) POPULATION IN SPAIN. RECAP-DM SPANISH COHORT STUDY

被引：0
|
作者：
Nocea, G. [1 ]
Melero, M. [2 ]
Caloto, M. T. [2 ]
机构：
[1] MSD Spain, Madrid, Spain
[2] Merck Sharp & Dohme Ltd, Madrid, Spain
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A498 / A498
页数：1
相关论文
共 50 条
  • [1] ASSOCIATION BETWEEN HYPOGLYCEMIA EPISODES AND CHANGES IN THE SULPHONYLUREA TREATMENT PATTERN IN TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS. RECAP-DM SPANISH COHORT STUDY
    Caloto, M. T.
    Nocea, G.
    Yin, D.
    VALUE IN HEALTH, 2008, 11 (06) : A499 - A499
  • [2] GALIPDIA study: Reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of Spain
    Villar-Taibo, Rocio
    Fernandez-Rodriguez, Eva
    Tejera-Perez, Cristina
    Diaz-Ortega, Carmen
    Sanchez-Sobrino, Paula
    Palmeiro-Carballeira, Regina
    Rodriguez-Novo, Nazareth
    Rodriguez-Carnero, Gemma
    Pinal-Osorio, Iria
    Cotovad-Bellas, Laura
    Diaz-Trastoy, Olaia
    Mantinan-Gil, Beatriz
    Alvarez-Castro, Paula
    Plata, Paula Andujar
    Seoane-Cruz, Ines
    Prieto-Tenreiro, Alma
    Argueso Armesto, Rosa
    Fernandez-Pombo, Antia
    Sanchez-Bao, Ana
    Vidal-Casariego, Alfonso
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2023, 70 (01): : 29 - 38
  • [3] POTENTIAL IMPACT OF LIPID CONTROL AND SUBSEQUENT CARDIOVASCULAR (CV) RISK REDUCTION IN T2DM POPULATION TREATED WITH ORAL COMBINATION THERAPY (OCT) RECAP-DM STUDY
    Nocea, G.
    Melero, M.
    Caloto, M. T.
    Yin, D.
    VALUE IN HEALTH, 2008, 11 (06) : A498 - A499
  • [4] PATIENT PREFERENCES FOR ATTRIBUTES OF TYPE 2 DIABETES MELLITUS (T2DM) TREATMENTS IN SPAIN
    Mansfield, C. A.
    Sikirica, M.
    Pugh, A.
    Poulos, C.
    Martin, A. A.
    Ruiz Moran, L.
    Morano Larragueta, R.
    VALUE IN HEALTH, 2015, 18 (07) : A614 - A614
  • [5] Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study)
    Dedov, Ivan
    Shestakova, Marina
    Benedetti, Massimo Massi
    Simon, Dominique
    Pakhomov, Iakov
    Galstyan, Gagik
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 115 : 90 - 95
  • [6] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [7] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [8] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [9] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [10] Characteristics of a large urban pediatric population with type 2 diabetes mellitus (T2DM)
    Katz, LEL
    Norris, R
    Weinzimer, SA
    Jawad, AF
    Preis, CM
    McKnight, H
    Murphy, KM
    DIABETES, 2001, 50 : A380 - A380
12345